Clinical trial
Identification of Acute Intermittent Porphyria Modifying Genes
NCT05502133 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Acute Intermittent Porphyria Modifying Genes
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 23, 2022
- Completion date
- June 30, 2029
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute intermittent porphyria (aip)